Bigfoot, the Loch Ness Monster, and Halogen Bonds

by Thanos Panagiotidis | Nov 22, 2018 | Drug Discovery Applications, Publications and presentations

Bigfoot, the Loch Ness Monster, and Halogen Bonds At the 2018 Streamlining Drug Discovery Symposium in San Diego, David Lawson treated us to this illuminating presentation entitled Bigfoot, the Loch Ness Monster, and Halogen Bonds: Separating Rumors from Reality in...

A Novel Scoring Profile for the Design of Antibacterials Active Against Gram-Negative Bacteria

by Thanos Panagiotidis | Nov 16, 2018 | Drug Discovery Applications, Publications and presentations

A Novel Scoring Profile for the Design of Antibacterials Active Against Gram-Negative Bacteria At the 2nd SCI/RSC Symposium on Antimicrobial Drug Discovery, 12-13 November 2018, Bailey Montefiore, Optibrium – Franca Klingler, BioSolveIT – Nicholas Foster,...

Imputation of Protein Activity Data Using Deep Learning

by Thanos Panagiotidis | Nov 14, 2018 | Drug Discovery Applications, Publications and presentations

Imputation of Protein Activity Data Using Deep Learning At the US Symposia, Streamlining Drug Discovery 2018 in Cambridge MA, Matthew Segall from Optibrium and Tom Whitehead from Intellegens presented Imputation of Protein Activity Data Using Deep Learning. You can...

WaterSwap to Assess Target Druggability

by Thanos Panagiotidis | Nov 12, 2018 | Drug Discovery Applications, Publications and presentations

WaterSwap to Assess Target Druggability At the 2018 Streamlining Drug Discovery Symposium in San Diego and San Francisco, Adam Kallel gave an insightful presentation on WaterSwap to Assess Target Druggability. You can download his slides as...

Using AI to Improve the Safety of New Drug Candidates

by Thanos Panagiotidis | Nov 8, 2018 | Drug Discovery Applications, Publications and presentations

Using AI to Improve the Safety of New Drug Candidates On 18 October 2018, at the Streamlining Drug Discovery Symposium in Cambridge MA, Nigel Greene gave this fascinating presentation on Using AI to Improve the Safety of New Drug Candidates. You can download his...

Recent Posts

  • Optibrium appoints Steve Yemm as Chief Commercial Officer
  • Introduction to StarDrop™
  • Real world case studies: Predicting pharmacokinetics from limited ADME data with deep learning
  • Inspyra™– Introduction
  • Cerella™– Introduction

Archives

Categories

  • Asteris
  • Cerella
  • Downloads
  • Drug Discovery Applications
  • Events
  • Example Code
  • General
  • In Silico Modelling
  • Latest Videos
  • Models
  • Multi-Parameter Optimisation
  • News
  • Ocura
  • Pipeline Pilot Protocols
  • Presentations and Webinars
  • Publications and presentations
  • Scoring Profiles
  • Scripts/Addons
  • StarDrop Hints and Tips
  • StarDrop Modules and Features
  • StarDrop Tutorials
  • Tutorials
  • Upcoming webinar
  • Videos
  • Webinars

Meta

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.

enquiries & support

General: [email protected]
StarDrop: [email protected]
Cerella: [email protected]
Press: [email protected]
Vacancies: [email protected]

  • Follow
  • Follow
further information

View our Privacy Policy

Copyright © 2023 Optibrium, Ltd. All Rights Reserved.
Optibrium™, StarDrop™, Augmented Chemistry®, Cerella™, Asteris™, Ocura™, Glowing Molecule™, WhichP450™, Auto-Modeller™, Nova™, MPO Explorer™ and Card View® are trademarks of Optibrium Ltd. Augmented Chemistry® is registered only in the UK and EU. Card View® is registered only in the United States. Matsy™ is a trademark of NextMove Software Ltd., BIOSTER™ is a trademark of iKem Szolgáltató és Kereskedelmi BT, Derek Nexus™ is a trademark of Lhasa Ltd., Surflex eSim3D is a trademark of BioPharmics LLC, and SeeSAR™ is a trademark of BioSolveIT GmbH. US Patent Numbers 9,224,098 and 9,367,812

Website designed and developed by Identity Creative.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}